North Richland Hills, Texas Clinical Trials

A listing of North Richland Hills, Texas clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 36 clinical trials
KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated Nonsquamous NSCLC

This is a Phase 2, randomized, multicenter, double-blind study of the glutaminase inhibitor telaglenastat with standard-of-care pembrolizumab and chemotherapy versus placebo with standard-of-care pembrolizumab and chemotherapy for first line treatment of metastatic disease in patients with KEAP1/NRF2-mutated, stage IV, nonsquamous, non-small cell lung cancer (NSCLC). The study primary endpoints are …

NTRK
measurable disease
ros1
BRAF
systemic therapy
Texas Oncology - Fort Worth Cancer Center
 (9.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +27 other locations
Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

recurrent langerhans cell histiocytosis
refractory hepatoblastoma
metastatic disease
radiopharmaceutical
genetic alteration
Cook Children's Medical Center
 (9.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +82 other locations
Pompe Disease Registry

The Pompe Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Pompe disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The objectives …

deficiency
gaa gene
myozyme
glycogen storage disease type ii
replacement therapy
Investigational Site Number 840024
 (9.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +190 other locations
Fabry Disease Registry & Pregnancy Sub-registry

The Fabry Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Fabry disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The primary …

agalsidase beta
deficiency
alpha-galactosidase
fabrazyme
fabry's disease
Investigational Site Number 840024
 (9.0 away) Contact site
  • 0 views
  • 05 Aug, 2024
  • +136 other locations
Micra AV Transcatheter Pacing System Post-Approval Registry

Medtronic is sponsoring the Micra AV Registry using the Micra AV system for continued surveillance of chronic atrioventricular synchronous pacing as intended, through the collection of data based on routine clinical care practice, following commercial release. The Micra AV Registry is conducted within Medtronic's Product Surveillance Registry (PSR) platform.

Consultants in Cardiology
 (9.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +38 other locations
NCI COVID-19 in Cancer Patients NCCAPS Study

This study collects blood samples, medical information, and medical images from patients who are being treated for cancer and have a positive test for SARS CoV-2, the new coronavirus that causes the disease called COVID-19. Collecting blood samples, medical information, and medical images may help researchers determine how COVID-19 affects …

mek inhibitor
coronavirus infection
nucleic acid
stem cell transplantation
cancer
UT Southwestern/Simmons Cancer Center-Fort Worth
 (9.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +575 other locations